Trade VCYT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Veracyte, Inc. (VCYT) is trading at US$39.80, down 1.91% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$3.4B. Over the past 52 weeks, VCYT has traded between US$29.46 and US$60.91. On Syfe you can trade VCYT with $0 commission and add it to your watchlist.
| Previous close | US$40.57 |
|---|---|
| Market cap | US$3.4B |
| P/E ratio | 20.50 |
| 52-week range | US$29.46 – US$60.91 |
| Volume | 2.67M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Veracyte, Inc.
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Year: 2013
Needham Raises Price Target on Veracyte to $69 From $57, Keeps Buy Rating
Jul 31, 11:18 AM · MT Newswires
Veracyte Q2 Non-GAAP Earnings, Revenue Rise; 2026 Revenue Guidance Raised
Jul 30, 9:32 PM · MT Newswires
Veracyte, Inc. (VCYT) stock is trading at US$39.80, -1.91% from the previous close of US$40.57.
The market cap for Veracyte, Inc. (VCYT) stock is approximately US$3.4B.
The price-to-earnings ratio for Veracyte, Inc. (VCYT) is 20.50, based on the latest reported earnings.
The 52-week high for Veracyte, Inc. (VCYT) stock is US$60.91.
The 52-week low for Veracyte, Inc. (VCYT) stock is US$29.46.
Veracyte, Inc. (VCYT) does not currently pay a dividend.
Stay on top of VCYT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
